A five-year retrospective study of treatment outcomes using the L-asparaginase-based regimen as a first-line chemotherapy protocol for patients diagnosed with extranodal NK/T-cell lymphoma, nasal-type, in Thailand.
CONCLUSIONS: L-asparaginase-based regimens offer a good outcome as a front-line treatment for ENKTL.
PMID: 33427594 [PubMed - as supplied by publisher]
Source: Hematology - Category: Hematology Tags: Hematology Source Type: research
More News: Bleeding | Chemotherapy | Hematology | Hypofibrinogenemia | Lymphoma | Skin | Stem Cell Therapy | Stem Cells | Study | T-cell Lymphoma | Thailand Health | Thrombosis | Transplants | Women